Two pharmaceutical companies, one based in China and one in the United States, are working together to develop a drug which will stop the spread of cancerous cells. The Sino-American companies are basing the operation in China, with the end result being the creation of the KDR/Kit Inhibitor. According to researchers, the drug will stop the growth of new cancer cells in the body, effectively stopping the spread of the disease. The drug is currently known as OSI-930, and has shown promising results in treating both small and non-small cell lung cancer, and the researchers are also investigating its effectiveness in treating mesothelioma.
If you or someone you love has developed mesothelioma as a result of asbestos exposure, contact the mesothelioma lawyers of Williams Kherkher by calling 800-781-3955 today.